Columbus Hill Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-728,540
Closed -$44.5M 60
2017
Q3
$44.5M Sell
728,540
-52,726
-7% -$3.2M 3.17% 10
2017
Q2
$47.8M Sell
781,266
-21,784
-3% -$1.33M 4.8% 5
2017
Q1
$48.7M Buy
803,050
+146,835
+22% +$8.91M 2.43% 12
2016
Q4
$36.9M Buy
656,215
+470,719
+254% +$27.5M 4.16% 9
2016
Q3
$11M Buy
+185,496
New +$10.8M 1.17% 25

Other funds holding MRK

Columbus Hill Capital Management's MRK Position: Q4 2017 in Review

Columbus Hill Capital Management sold out of Merck (MRK) in Q4 2017, closing a stake of 728,540 shares — an estimated $44.5M sold.

Columbus Hill Capital Management first reported a position in MRK in Q3 2016 and held it in 5 quarters. The position peaked at $48.7M in Q1 2017. 2,008 funds tracked by Wall St. Rank hold MRK as of Q4 2017.

  • Columbus Hill Capital Management reported no remaining Merck position as of Q4 2017 after selling out during the quarter.
  • Columbus Hill Capital Management sold 728,540 Merck shares in Q4 2017, an estimated $44.5M.
  • Columbus Hill Capital Management first reported a position in Merck in Q3 2016 and held it in 5 quarters.
  • Columbus Hill Capital Management's Merck position peaked at $48.7M in Q1 2017.
  • 2,008 funds tracked by Wall St. Rank held Merck as of Q4 2017.

Based on Columbus Hill Capital Management's 13F filing for Q4 2017, filed 13 Feb 2018.